Skip to content
Search

Latest Stories

NHS Trust signs 10-year deal with tech firm for digital-first integrated care

Royal Wolverhampton NHS Trust and technology company Babylon has announced a 10-year partnership to develop a new ‘Digital-First Integrated Care’ delivery model.

Staff and patients at the Trust will use a single free app, which will connect primary and secondary care.


The app allows patients to access clinical consultations with doctors and specialist nurses, giving them full control of appointment booking and prescriptions. They can also access the ‘Personal Clinical Records’ and see their medical history and lifestyle.

The NHS Trust, which runs three hospitals, expects the app to benefit 300,000 people across Wolverhampton and its surroundings with faster treatments and fewer trips to the hospital.

“As medicine transforms over the next 10 years, and cutting-edge technology improves, it is critical that the NHS develops a digitally empowered workforce. With the Trust’s end-to-end care portfolio this is a huge opportunity for us and Babylon to constructively tackle all of these things together,” said David Loughton, Trust Chief Executive.

“I am confident that this won’t be just good for our patients, it will benefit the wider NHS through early prevention, treatment and the sharing of our learning."

Babylon’s artificial intelligence-underpinned personalised care plans will also offer proactive care of patients with chronic diseases and give users medical information and triage advice.

Ali Parsa, CEO and Founder of Babylon, said: “We have over 1,000 AI experts, clinicians, engineers and scientists who will be helping to make Digital-First Integrated Care a reality and provide fast, effective, proactive care to patients. Together with RWT, we can demonstrate this works and help the NHS lead healthcare across the world”.

The first new services are expected to go live before the end of 2020.

More For You

Scottish community pharmacist working in high street pharmacy with supportive environment

The PDA wants investment to reach those who deliver services to patients every day

Pic credit: iStock

Funding boost in Scotland “needs to work for not just pharmacy owners but pharmacists too”, says PDA

An increase in funding for community pharmacies in Scotland needs to lead to a greater focus on supporting pharmacists rather than “simply sustain business models”, according to the Pharmacy Defence Association (PDA).

Earlier this week, Community Pharmacy Scotland (CPS) accepted the Scottish government’s initial financial offer for the 2025/26 fiscal year, securing a guaranteed minimum reimbursement of £120 million for community pharmacies — up from £110 million from 2024/25.

Keep ReadingShow less
Aspire Pharma acquisition boosts access to essential medicines for NHS patients in the UK

The acquisition is expected to further drive the company’s growth.

gettyimages

Aspire acquires UK distribution rights from Tetris

Aspire Pharma Limited, one of the UK’s fastest-growing specialty niche generics companies, has announced the acquisition of UK distribution rights to a number of products from Tetris Pharma, a subsidiary of Arecor Therapeutics.

These include products used in the treatment of bacterial infections—such as injectable and intravenous antibiotics—as well as a medicine indicated for acute myocardial infarction (MI) and deep vein thrombosis (DVT).

Keep ReadingShow less
GP surgery upgrades for annual appointments

The surgeries will have additional space to “see more patients, boost productivity and improve patient care”

Pic credit: iStock

GP surgery upgrades to create 8.3 million more annual appointments

Over 1,000 GP surgeries will have their premises modernised to meet the needs of a further 8.3 million appointments each year, the government has announced.

Backed by a cash injection of over £102 million, the surgeries will have additional space to “see more patients, boost productivity and improve patient care”.

Keep ReadingShow less
Wales boosts funding for pharmacy-led UTI and sore throat test services

The sore throat test (STTT) and treat service will be widely available

Pic credit: istock

Welsh pharmacies receive funding boost for clinical services

Two key clinical services will be available in 99 per cent of community pharmacies across Wales after a boost in funding.

The sore throat test (STTT) and treat service and the urinary tract infection (UTI) service have both benefitted from contractual negotiations between the Welsh Government and Community Pharmacy Wales (CPW).

Keep ReadingShow less
Paul Bennett
Paul Bennett, CEO, Royal Pharmaceutical Society
Paul Bennett, CEO, Royal Pharmaceutical Society

Pharmacists need to take advantage of independent prescribing pathways, says Bennett

Independent prescribing will be a “significant point” in the history of community pharmacy, according to Royal Pharmaceutical Society chief executive Paul Bennett.

Last month, the RPS announced the launch of a comprehensive new prescribing development programme to support pharmacists across all stages of their prescribing careers.

Keep ReadingShow less